The same gene was also significant in DriverPower’s CDS result for Lymph-BNHL (Supplementary Fig. 14e), resulting in a total of 13.3% (14/105) Lymph-BNHL samples being affected by non-synonymous or splice site mutations in SGK1. SGK1 is present in PCAWG-raw but was filtered out owing to the large number of AID-related variants in this tumour cohort. This evidence concerns the gene SGK1 and neoplasm.